I completed a BSc in Biomedicine and an MSc in Immunology, followed by almost 4 years working as a scientist for a biotech company in Oslo. My research interests are centred around harnessing the immune system for targeted and efficient therapy of cancer – immunotherapy.
My PhD project aims to evaluate efficacy of bi-specific engager molecules targeting CD16a on NK cells and tumour associated antigens on target cells in animal models of cancer (model TBC).
Two obligatory questions!
1. What brought you to PRIMA?
I was very excited to hear about the new centre of excellence, PRIMA, which shares my goal of developing the next generation of precision immunotherapy. Together we can make it happen!
2. What are you passionate about?
Other interests in my life are related to being in the mountains, either skiing, hiking or running. I also climb on a weekly basis.